St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Front Immunol. 2022 Jun 24;13:869047. doi: 10.3389/fimmu.2022.869047. eCollection 2022.
We report the case of a male Pakistani patient with a pathogenic homozygous loss of function variant in the non-homologous end-joining factor 1 () gene. The growth retarded and microcephalic boy with clinodactyly of both hands and hyperpigmentation of the skin suffered from recurrent respiratory infections. He was five and a half years old when he came to our attention with refractory cytopenia and monosomy 7. Hematopoietic stem cell transplantation was considered but not feasible because there was no suitable donor available. Monosomy 7 was not detected anymore in subsequent bone marrow biopsies that were repeated in yearly intervals. Instead, seven and a half years later, a novel clone with a del(20q) appeared and steadily increased thereafter. In parallel, the patient's blood count, which had remained stable for over 20 years without necessitating any specific therapeutic interventions, improved gradually and the erythropoiesis-associated dysplasia resolved.
我们报告了一例巴基斯坦男性患者,其存在非同源末端连接因子 1 ()基因的纯合致病性功能丧失变异。这个生长迟缓、小头畸形、双手内弯的男孩伴有皮肤色素沉着,反复发生呼吸道感染。他五岁半时因难治性血细胞减少症和单体 7 前来就诊。虽然考虑了造血干细胞移植,但由于没有合适的供体,因此不可行。随后的骨髓活检中未再发现单体 7,这些活检在每年间隔时间重复进行。相反,七年后半,出现了一个新的克隆,具有 del(20q),此后该克隆不断增加。与此同时,患者的血液计数在 20 多年来一直保持稳定,无需任何特定的治疗干预,逐渐改善,并且与红细胞生成相关的发育异常也得到了缓解。